Deep Learning Segmentation of Chromogenic Dye RNAscope From Breast Cancer Tissue.

Journal: Journal of imaging informatics in medicine
Published Date:

Abstract

RNAscope staining of breast cancer tissue allows pathologists to deduce genetic characteristics of the cancer by inspection at the microscopic level, which can lead to better diagnosis and treatment. Chromogenic RNAscope staining is easy to fit into existing pathology workflows, but manually analyzing the resulting tissue samples is time consuming. There is also a lack of peer-reviewed, performant solutions for automated analysis of chromogenic RNAscope staining. This paper covers the development and optimization of a novel deep learning method focused on accurate segmentation of RNAscope dots (which signify gene expression) from breast cancer tissue. The deep learning network is convolutional and uses ConvNeXt as its backbone. The upscaling portions of the network use custom, heavily regularized blocks to prevent overfitting and early convergence on suboptimal solutions. The resulting network is modest in size for a segmentation network and able to function well with little training data. This deep learning network was also able to outperform manual expert annotation at finding the positions of RNAscope dots, having a final -score of 0.745. In comparison, the expert inter-rater -score was 0.596.

Authors

  • Andrew Davidson
    Department of Computer Science and Software Engineering, University of Canterbury, Christchurch, New Zealand. andrew.davidson@pg.canterbury.ac.nz.
  • Arthur Morley-Bunker
    Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • George Wiggins
    Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Logan Walker
    Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
  • Gavin Harris
    Canterbury Health Laboratories, Christchurch, New Zealand.
  • Ramakrishnan Mukundan
    Department of Computer Science and Software Engineering, University of Canterbury, Christchurch, New Zealand.
  • kConFab Investigators
    Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.